Ptc Therapeutics (PTCT) Other Working Capital Changes (2017 - 2026)
Ptc Therapeutics (PTCT) posted quarterly Other Working Capital Changes of $718000.0 for Q2 2026, up 121.4% year-over-year from $324298.6 in Q2 2025, and up 147.17% quarter-over-quarter from -$1.5 million in Q1 2026.
Powered by 
Analysis
Ptc Therapeutics (PTCT) Other Working Capital Changes (2017 - 2026) Analysis & Trends
Ptc Therapeutics' Other Working Capital Changes history runs 14 years deep, the most recent figure standing at $718000.0 for Q2 2026.
- In Q2 2026, Other Working Capital Changes rose 121.4% year-over-year to $718000.0; the TTM figure through Jun 2026 stood at -$8.6 million (down 190.42% YoY), while the FY2025 annual figure was -$4.0 million, down 181.31% from the prior year.
- Other Working Capital Changes for Q2 2026 stood at $718000.0, up from -$1.5 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $104.5 million in Q4 2023, with the low at -$93.9 million in Q1 2024.
- The 5-year median for Other Working Capital Changes is $249500.0 (2025), against an average of $1.4 million.
- The sharpest annual moves came in 2024 and 2026: Other Working Capital Changes soared 1451.77% in 2024, then plunged 121.14% in 2026.
- Ptc Therapeutics' Other Working Capital Changes stood at -$423000.0 in 2023, then jumped by 1451.77% to $5.7 million in 2024, then plunged by 94.75% to $300000.0 in 2025, then soared by 139.33% to $718000.0 in 2026.
- Business Quant data shows PTCT's Other Working Capital Changes at $718000.0 in Q2 2026, -$1.5 million in Q1 2026, and $300000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Ptc Therapeutics | 5.78 Bn | 3.55 Bn | 340.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 718,000.00 |
| Jun 30, 2026 | 718,000.00 |
| Mar 31, 2026 | -1.52 Mn |
| Mar 31, 2026 | -1.52 Mn |
| Dec 31, 2025 | 300,000.00 |
| Dec 31, 2025 | 300,000.00 |
| Sep 30, 2025 | -8.14 Mn |
| Sep 30, 2025 | -8.14 Mn |
| Jun 30, 2025 | -3.36 Mn |
| Jun 30, 2025 | -3.36 Mn |
| Mar 31, 2025 | 7.20 Mn |
| Mar 31, 2025 | 7.20 Mn |
| Dec 31, 2024 | 5.72 Mn |
| Dec 31, 2024 | 5.72 Mn |
| Mar 31, 2024 | -801,000.00 |
| Mar 31, 2024 | -801,000.00 |
| Dec 31, 2023 | -423,000.00 |
| Dec 31, 2023 | -423,000.00 |
| Sep 30, 2023 | 1.22 Mn |
| Sep 30, 2023 | 1.22 Mn |